BCL2 mutations in diffuse large B-cell lymphoma (Q42772985)

7 November 2017

BCL2 mutations in diffuse large B-cell lymphoma (English)

1 reference

7 November 2017

0 references

J M Schuetz

1

1 reference

7 November 2017

N A Johnson

2

1 reference

7 November 2017

R D Morin

3

1 reference

7 November 2017

D W Scott

4

1 reference

7 November 2017

K Tan

5

1 reference

7 November 2017

S Ben-Nierah

6

1 reference

7 November 2017

M Boyle

7

1 reference

7 November 2017

G W Slack

8

1 reference

7 November 2017

M A Marra

9

1 reference

7 November 2017

J M Connors

10

1 reference

7 November 2017

A R Brooks-Wilson

11

1 reference

7 November 2017

R D Gascoyne

12

1 reference

7 November 2017

22 December 2011

1 reference

7 November 2017

1 reference

7 November 2017

26

1 reference

7 November 2017

6

1 reference

7 November 2017

1383-1390

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2011.378

7 November 2017

0 references

cites work

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Structural conservation of residues in BH1 and BH2 domains of Bcl-2 family proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Mapping and quantifying mammalian transcriptomes by RNA-Seq

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Fast and accurate short read alignment with Burrows-Wheeler transform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Human non-synonymous SNPs: server and survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

The biochemistry of somatic hypermutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Two levels of protection for the B cell genome during somatic hypermutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Bcl2's flexible loop domain regulates p53 binding and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Conversion of Bcl-2 to a Bax-like death effector by caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

The polymorphic 43Thr bcl-2 protein confers relative resistance to autoimmunity: an analytical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Defining the p53 DNA-binding domain/Bcl-x(L)-binding interface using NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

7 January 2021

Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

7 January 2021

Variant t(14;18) in malignant lymphoma: a report of seven cases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

7 January 2021

The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.378

7 January 2021

Identifiers

DOI

10.1038/LEU.2011.378

1 reference

Dimensions Publication ID

7 November 2017

0 references

1 reference